A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 1, 2003, Pages 78-81

  Cundy, Tim ^a,b   Ames, Ruth ^a   Horne, Anne ^a   Clearwater, Judy ^a   Roberts, Helen ^b   Gamble, Greg ^a   Reid, Ian R ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BONE DENSITY; BONE MINERAL; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; OSTEOLYSIS; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA BLEEDING;

ADULT; BONE DENSITY; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MEDROXYPROGESTERONE 17-ACETATE;

EID: 0037240976     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020874     Document Type: Article

References (15)

1. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR 1991 Bone density in women receiving depot medroxyprogesterone acetate contraception. Br Med J 303:13-16 (correction, p. 209)
2. Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z 1996 A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 129:671-676
3. Gbolade B, Ellis S, Murby B, Randall S, Kirkman R 1998 Bone density in long term users of depot medroxyprogesterone acetate. Br J Obstet Gynaecol 105:790-7944
4. Cundy T, Cornish J, Roberts H, Elder H, Reid IR 1998 Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 92:569-5735
5. Paiva LC, Pinto-Neto AM, Faundes A 1998 Bone density amongst long term users of medroxyprogesterone acetate as a contraceptive. Contraception 58:351-3556
6. Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE 1999 Bone mineral density in women using depot medroxyprogesterone for contraception. Obstet Gynecol 93:233-238
7. Tang OS, Tang G, Yip P, Li B, Fan S 1999 Long-term depot medroxyprogesterone acetate and bone mineral density. Contraception 59:25-29
8. Jeppsson S, Gershagen S, Johansson EDB, Rannevik G 1982 Serum medroxyprogesterone (MPA), sex hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long term use of depo-MPA as a contraceptive. Acta Endocrinol 99:339-343
9. Clark MK, Sowers M, Levy BT, Tenhundfeld P 2001 Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception. Fertil Steril 75:871-877
10. Ott SM, Scholes D, LaCroix AZ, Ichikawa LE, Yoshida CK, Barlow WE 2001 Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab 86:179-185
11. Cundy T, Cornish J, Evans MC, Roberts H, Reid IR 1994 Recovery of bone density in women who stop using medroxyprogesterone acetate. Br Med J 308:247-248
12. Cundy T, Roberts H, Cornish J, Reid IR 2002 Menopausal bone loss in long term users of depot medroxyprogesterone acetate contraception. Am J Obstet Gynecol 186:978-983
13. Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC 1994 Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am J Med 96:521-529
14. Grey A, Cundy T, Evans MC, Reid IR 1996 Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late postmenopausal women. Clin Endocrinol 44:293-296
15. Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR 2000 Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women. Arch Intern Med 160:2161-2166